|
|
||||||||

Departments of
*
Cell Biology and Genetics and
Immunology, Faculty of Medicine, Erasmus University, Rotterdam, The Netherlands
Brutons tyrosine kinase (Btk) is a nonreceptor protein kinase that is defective in X-linked agammaglobulinemia in humans and in X-linked immunodeficiency in mice. To study the effect of Btk activation in early B cell development in vivo, we have created transgenic mouse strains expressing Btk under the control of the human CD19 promoter region. The transgenic expression of wild-type human Btk corrected all X-linked immunodeficiency features in mice carrying a targeted disruption of the Btk gene. In contrast, expression of an activated form of Btk, the E41K mutant, resulted in an almost complete arrest of B cell development in the immature IgM+IgD- B cell stage in the bone marrow, irrespective of the presence of the endogenous intact Btk gene. Immature B cells were arrested at the progression from IgMlow into IgMhigh cells, which reflects the first immune tolerance checkpoint at which autoreactive B cells become susceptible to apoptosis. As the constitutive activation of Btk is likely to mimic B cell receptor occupancy by autoantigens in the bone marrow, our findings are consistent with a role for Btk as a mediator of B cell receptor-induced apoptotic signals in the immature B cell stage. Whereas the peripheral mature B cell pool was reduced to <1% of the normal size, significant numbers of IgM-secreting plasma cells were present in the spleen. Serum IgM levels were substantial and increased with age, but specific Ab responses in vivo were lacking. We conclude that the residual peripheral B cells were efficiently driven into IgM+ plasma cell differentiation, apparently without functional selection.
This article has been cited by other articles:
![]() |
J. C. Nixon, S. Ferrell, C. Miner, A. L. Oldham, U. Hochgeschwender, and C. F. Webb Transgenic Mice Expressing Dominant-Negative Bright Exhibit Defects in B1 B Cells J. Immunol., November 15, 2008; 181(10): 6913 - 6922. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Walter, C. Bonifer, and H. Tagoh Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus Blood, September 1, 2008; 112(5): 1673 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shankar, J. C. Nixon, S. Maier, J. Workman, A. D. Farris, and C. F. Webb Anti-Nuclear Antibody Production and Autoimmunity in Transgenic Mice That Overexpress the Transcription Factor Bright J. Immunol., March 1, 2007; 178(5): 2996 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kersseboom, V. B. T. Ta, A. J. E. Zijlstra, S. Middendorp, H. Jumaa, P. Fokko van Loo, and R. W. Hendriks Bruton's Tyrosine Kinase and SLP-65 Regulate Pre-B Cell Differentiation and the Induction of Ig Light Chain Gene Rearrangement. J. Immunol., April 15, 2006; 176(8): 4543 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chen, Y.-H. Wang, Y. Wang, L. Huang, H. Sandoval, Y.-J. Liu, and J. Wang Dendritic cell apoptosis in the maintenance of immune tolerance. Science, February 24, 2006; 311(5764): 1160 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohtsuka, H. Arase, A. Takeuchi, S. Yamasaki, R. Shiina, T. Suenaga, D. Sakurai, T. Yokosuka, N. Arase, M. Iwashima, et al. NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling PNAS, May 25, 2004; 101(21): 8126 - 8131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nolte, R. Arens, M. Kraus, M. H. J. van Oers, G. Kraal, R. A. W. van Lier, and R. E. Mebius B Cells Are Crucial for Both Development and Maintenance of the Splenic Marginal Zone J. Immunol., March 15, 2004; 172(6): 3620 - 3627. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Otero and R. C. Rickert CD19 Function in Early and Late B Cell Development. II. CD19 Facilitates the Pro-B/Pre-B Transition J. Immunol., December 1, 2003; 171(11): 5921 - 5930. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Middendorp, G. M. Dingjan, A. Maas, K. Dahlenborg, and R. W. Hendriks Function of Bruton's Tyrosine Kinase during B Cell Development Is Partially Independent of Its Catalytic Activity J. Immunol., December 1, 2003; 171(11): 5988 - 5996. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kersseboom, S. Middendorp, G. M. Dingjan, K. Dahlenborg, M. Reth, H. Jumaa, and R. W. Hendriks Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B Cells J. Exp. Med., July 7, 2003; 198(1): 91 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saijo, I. Mecklenbrauker, A. Santana, M. Leitger, C. Schmedt, and A. Tarakhovsky Protein Kinase C {beta} Controls Nuclear Factor {kappa}B Activation in B Cells Through Selective Regulation of the I{kappa}B Kinase {alpha} J. Exp. Med., June 17, 2002; 195(12): 1647 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Nawijn, G. M. Dingjan, R. Ferreira, B. N. Lambrecht, A. Karis, F. Grosveld, H. Savelkoul, and R. W. Hendriks Enforced Expression of GATA-3 in Transgenic Mice Inhibits Th1 Differentiation and Induces the Formation of a T1/ST2-Expressing Th2-Committed T Cell Compartment In Vivo J. Immunol., July 15, 2001; 167(2): 724 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Dingjan, S. Middendorp, K. Dahlenborg, A. Maas, F. Grosveld, and R. W. Hendriks Bruton's Tyrosine Kinase Regulates the Activation of Gene Rearrangements at the {lambda} Light Chain Locus in Precursor B Cells in the Mouse J. Exp. Med., May 21, 2001; 193(10): 1169 - 1178. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |